Literature DB >> 20846897

Structural analysis of cytokines comprising the IL-10 family.

Alexander Zdanov1.   

Abstract

Interleukin-10 (IL-10) family of cytokines includes a number of its viral homologs and eight cellular cytokines (IL-19, IL-20, IL-22, IL-24, IL-26, IL-28A, IL-28B, and IL-29). The latter three proteins are also known as IFN-λ2, IFN-λ3, and IFN-λ1, and are recognized as type III (or λ) interferons. Most of the cellular homologs of IL-10 are monomeric in solution, whereas IL-10 and its viral homologs are intercalated dimers consisting of two helical bundle domains topologically similar to the monomeric members of the family. A classical four-helix bundle, a signature element of all helical cytokines, is always found as part of the domain of each member of the IL-10 family. The only crystal structures of these cytokine receptors that have been determined to date are for their extracellular domains (ECDs). Each ECD consists of two β-sandwich domains connected in the middle by a linkage. Signal transduction occurs when a cytokine binds to its two appropriate receptor chains. IL-10 and its viral homologs use the same IL-10 receptor system, whereas the cellular homologs of IL-10 use their own receptors, which in some cases may overlap and be used in different pairwise combinations. The known structures of binary complexes allowed for marking of the receptor binding site, which always includes helix A, loop AB and helix F (IL-10 notations) on the side of a ligand, loops of the N-terminal and C-terminal domains directed toward the ligand, and the interdomain linkage of the ECD. An analysis of the published structures of both the binary and ternary complexes of all helical cytokines allowed for the generation of a model of the signaling complex of IL-10. The receptor binding site I of the high affinity receptor IL-10R1 is exactly the same as in the crystal structure of the binary IL-10/sIL-10R1 complex, whereas the receptor binding site II is located on the surface of the first and the third helices of the four-helix bundle. The receptor/receptor interface, or site III, is formed between the C-terminal domains of IL-10R1 and IL-10R2. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846897      PMCID: PMC2997900          DOI: 10.1016/j.cytogfr.2010.08.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  92 in total

1.  Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1.

Authors:  K Josephson; D T McPherson; M R Walter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-11-21

2.  A new nomenclature for IL-1-family genes.

Authors:  J E Sims; M J Nicklin; J F Bazan; J L Barton; S J Busfield; J E Ford; R A Kastelein; S Kumar; H Lin; J J Mulero; J Pan; Y Pan; D E Smith; P R Young
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

Review 3.  Type I interferons and limitin: a comparison of structures, receptors, and functions.

Authors:  K Oritani; P W Kincade; C Zhang; Y Tomiyama; Y Matsuzawa
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

4.  Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.

Authors:  L Dumoutier; C Leemans; D Lejeune; S V Kotenko; J C Renauld
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

5.  A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.

Authors:  W Xu; S R Presnell; J Parrish-Novak; W Kindsvogel; S Jaspers; Z Chen; S R Dillon; Z Gao; T Gilbert; K Madden; S Schlutsmeyer; L Yao; T E Whitmore; Y Chandrasekher; F J Grant; M Maurer; L Jelinek; H Storey; T Brender; A Hammond; S Topouzis; C H Clegg; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 6.  Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions.

Authors:  Laure Dumoutier; Jean-Christophe Renauld
Journal:  Eur Cytokine Netw       Date:  2002 Jan-Mar       Impact factor: 2.737

7.  The interleukin-10 family of cytokines.

Authors:  Helmut Fickenscher; Simon Hör; Heide Küpers; Andrea Knappe; Sabine Wittmann; Heinrich Sticht
Journal:  Trends Immunol       Date:  2002-02       Impact factor: 16.687

8.  Crystallization and synchrotron X-ray diffraction studies of human interleukin-22.

Authors:  R A P Nagem; K W Lucchesi; D Colau; L Dumoutier; J-C Renauld; I Polikarpov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-02-21

9.  Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2.

Authors:  Mai Wang; Zhongjia Tan; Rong Zhang; Sergei V Kotenko; Peng Liang
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

10.  Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1.

Authors:  Brandi C Jones; Naomi J Logsdon; Kristopher Josephson; Jennifer Cook; Peter A Barry; Mark R Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

View more
  25 in total

1.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

2.  Cell-Specific Requirements for STAT Proteins and Type I IFN Receptor Signaling Discretely Regulate IL-24 and IL-10 Expression in NK Cells and Macrophages.

Authors:  Djeneba Dabitao; Christian M Hedrich; Fengying Wang; Vimvara Vacharathit; Jay H Bream
Journal:  J Immunol       Date:  2018-02-07       Impact factor: 5.422

3.  Interleukin-37 monomer is the active form for reducing innate immunity.

Authors:  Elan Z Eisenmesser; Adrian Gottschlich; Jasmina S Redzic; Natasia Paukovich; Jay C Nix; Tania Azam; Lingdi Zhang; Rui Zhao; Jeffrey S Kieft; Erlinda The; Xianzhong Meng; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-28       Impact factor: 11.205

Review 4.  Role of IL-10 in the progression of kidney disease.

Authors:  Inna Sinuani; Ilia Beberashvili; Zhan Averbukh; Judith Sandbank
Journal:  World J Transplant       Date:  2013-12-24

Review 5.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

6.  IL10 receptor is a novel therapeutic target in DLBCLs.

Authors:  W Béguelin; S Sawh; N Chambwe; F C Chan; Y Jiang; J-W Choo; D W Scott; A Chalmers; H Geng; L Tsikitas; W Tam; G Bhagat; R D Gascoyne; R Shaknovich
Journal:  Leukemia       Date:  2015-03-03       Impact factor: 11.528

7.  Purification, crystallization and preliminary X-ray diffraction analysis of the IL-20-IL-20R1-IL-20R2 complex.

Authors:  Naomi J Logsdon; Christopher E Allen; Kanagalaghatta R Rajashankar; Mark R Walter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

Review 8.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

Review 9.  The molecular basis of IL-10 function: from receptor structure to the onset of signaling.

Authors:  Mark R Walter
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

10.  Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy.

Authors:  Georg Künze; Sebastian Köhling; Alexander Vogel; Jörg Rademann; Daniel Huster
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.